Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
1.770
-0.010 (-0.56%)
At close: Oct 30, 2025, 4:00 PM EDT
1.770
0.00 (0.00%)
After-hours: Oct 30, 2025, 4:00 PM EDT
Repare Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts that cover Repare Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $3.50, which forecasts a 97.74% increase in the stock price over the next year. The lowest target is $3.00 and the highest is $4.00.
Price Target: $3.50 (+97.74%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Repare Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $3 | Strong Buy | Maintains | $5 → $3 | +69.49% | Oct 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $5 | Strong Buy | Maintains | $10 → $5 | +182.49% | Mar 7, 2025 |
| LifeSci Capital | LifeSci Capital | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 13, 2024 |
| Stifel | Stifel | Strong Buy Maintains $9 → $4 | Strong Buy | Maintains | $9 → $4 | +125.99% | Dec 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +464.97% | Nov 8, 2024 |
Financial Forecast
Revenue This Year
10.51M
from 53.48M
Decreased by -80.35%
Revenue Next Year
10.20M
from 10.51M
Decreased by -2.91%
EPS This Year
-1.44
from -2.00
EPS Next Year
-0.92
from -1.44
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.8M | 21.0M | |||
| Avg | 10.5M | 10.2M | |||
| Low | 10.1M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -79.8% | 99.9% | |||
| Avg | -80.4% | -2.9% | |||
| Low | -81.1% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.48 | -0.95 | |
| Avg | -1.44 | -0.92 | |
| Low | -1.38 | -0.88 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.